The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits

Documenta Ophthalmologica

Volumn 95, Issue 2, 1998, Pages 165-179

  Čejková, Jitka ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Contact lenses; Rabbit cornea; u PA activity

Indexed keywords

7 AMINO 4 TRIFLUOROMETHYLCOUMARIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA CELL; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA OPACITY; CORNEA STROMA; CORNEA ULCER; CORNEA VASCULARIZATION; ENZYME ACTIVITY; EYE INFECTION; HISTOCHEMISTRY; INFLAMMATORY CELL; NEUTROPHIL; NONHUMAN; RABBIT; SOFT CONTACT LENS;

ANIMALS; BIOLOGICAL MARKERS; CONTACT LENSES, HYDROPHILIC; CORNEA; CORNEAL DISEASES; FOLLOW-UP STUDIES; RABBITS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032317387     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1001800130446     Document Type: Article

References (63)

1. Tervo T, Van Setten GB, Andersson R, Salonen E-M, Vaheri A, Immonen I, Tarkkanen A. Contact lens wear is associated with the appearance of plasmin in the tear fluid: preliminary results. Graefes Arch Clin Exp Ophthalmol 1989; 227: 42-4.
2. Van Setten GB, Tervo T, Andersson R, Perheentupa J, Tarkkanen A. Plasmin and epidermal growth factor in the tear fluid of contact-lens wearers: effect of wearing different types of contact lenses and association with clinical findings. Ophthalmic Res 1990; 22: 233-40.
3. Čejková J, Lojda Z, Vacik J, Digenis JA, Dročová S. Histochemical changes in the rabbit cornea and plasmin activity in the tear fluid during contact lens wear. Favourable influence of protease inhibitors (aprotinin, PCS, elastatinal). Histochemistry 1992; 97: 69-76.
4. Vannas A, Sweeney FD, Holden BA, Sapyska E, Salonen E-M, Vaheri A. Tear plasmin activity with contact lens wear. Current Eye Res 1992; 11: 243-51.
5. Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89.
6. Tripathi BJ, Geanon JD, Tripathi RC. Distribution of tissue plasminogen activator in human and monkey eyes: an immunohistochemical study. Ophthalmology 1987; 94: 1434-8.
7. Tripathi RC, Park JK, Tripathi BJ. Tissue plasminogen activator synthesis by trabecular cells and its implication for fibrinolytic therapy of the eye. Drug Dev Res 1989; 18: 245-53.
8. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 1985; 823: 35-65.
9. Blasi F, Vassalli J-D, Dano K. Urokinase-type plasminogen activator; proenzyme, receptor, and inhibitors. J Cell Biol. 1987; 104: 801-4.
10. Barlati 5, Marchina E, Quaranta CA, Vigasio F, Semeraro F . Analysis if fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair. Exp Eye Res 1990; 51: 1-9.
11. Vaheri, A, Bizik, J, Salonen, E-M, Tapiovaara, H, Sirén, V, Myohanen, H, Stephens, RW. Regulation of the pericellular activation of plasminogen and its role in tissue-destructive processes. Acta Ophthalmologica 1992, Suppl. 202: 34-41.
12. Tripathi RC, Tripathi BJ, Park JK. Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study. Exp Eye Res 1990; 51: 545-52.
13. Lojda Z, Gossrau R, Stoward P. Proteases. In Stoward, PJ and Pearse AGE (Eds). Histochemistry. Theoretical and applied, 4th ed, Vol 3, Churchill Livingstone, Edinburgh, London, Melbourne, New York and Tokyo, 1991; pp. 281-335.
14. Kennett CN, Cox SW, Elley BM. Comparative histochemical, biochemical and immunocytochemical studies of cathepsin B in human gingiva. J Periodont Res 1994; 29: 201-13.
15. Lojda Z. The use of substrates with 7-amino-4-trifluoromethylcoumarmne (AFC) leaving group in the localization of protease activities in situ. Acta histochem 1996; 98: 215-28.
16. Čejková J, Lojda Z. The appearance of active plasminogen activator of urokinase type (u-PA) in the rabbit anterior eye segment irradiated by UVB rays. A histochemical and biochemical study. Acta histochemica 1995; 97: 257-62.
17. Čejková J. The distinguishing between active plasminogen activators (PAs) and plasmin using sensitive substrates containing the leaving group 7-amino-4-trifluoromethylaminocoumarin (AFC) and enzyme inhibitors. Acta Histochemica et Cytochemica 1996; 29: (Supplement) 613-4.
18. Raap AK. Localization properties of fluorescence cytochemical enzyme procedures. Histochemistry 1986; 84: 317-21.
19. Smith RE, Reynolds CJ, Elder EA. The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV. Histochemical J. 1992; 24: 637-47.
20. Lojda Z, Gossrau R, Schiebler TH. Enzyme Histochemistry. A laboratory manual. Springer,Berlin, Heidelberg, New York, 1979.
21. Čejková J. Histochemical study of leukocyte elastase activity in alkali burned rabbit cornea. Ophthalmic Res, 1997; 29: 154-60.
22. Huseby RM, Clavin SA, Smith RE, Hull RN, Smithwick Jr EL. Studies on tissue culture plasminogen activator II. The detection and assay of urokinase and plasminogen activator from LLC-PK, cultures (porcine) by the synthetic substrate Na-benzyloxycarbonyl-glycly-glycly-arginyl-4-methoxy-2-naphthylamide. Thrombosis Res 1977; 10: 679-86.
23. Berman M, Leary R, Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest Ophthalmol Vis Sci 1980; 19: 1204-21.
24. Berman M, Hayashi K, Young E, Pease S, Smith D, El-Ghatit A, Askew M, Cragoe Jr EJ. Urokinase-like plasminogen activator, corneal epithelial migration and defect formation. Invest Ophthalmmol Vis Sci 1989; 30: (Suppl); 2.
25. Hayashi, K, Berman, M, Smith, D, El-Ghatit, A, Pease, S, Kenyon, KR. Pathogenesis of corneal epithelial defects: role of plasminogen activator. Current Eye Res 1991; 10: 38 1-98.
26. Pandolfi M, Lantz E. Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea. Exp Ey Res 1979; 29: 563-71.
27. Lojda Z, Čejková, J. Biochemical and histochemical studies of plasminogen activator of urokinase type. I. A simple rapid semiquantitative method for its detection in the tear fluid. Acta histochem 1993; 95, 232-7.
28. Gilboa N, Vullannueva G, Fenton J. Inhibition of fibrinolytic enzymes by thrombin inhibitors. Enzyme 1988; 40: 144-148.
29. Vassali J-D, Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Letters; 214: 187-91.
30. Schuman MA. Merkel CH. Urokinase binding to bovine corneal endothelial cells. Exp Eye Res 1985; 41: 371-82.
31. Wang H-M, Berman M, Law M. Latent and active plasminogen activator in corneal ulceration. Invest Ophthalmol Vis Sci 1985; 26: 511-24.
32. Lantz E, Pandolfi M. Fibrinolysis in cornea and conjunctiva: evidence of two types of activators. Albrecht von Graefes Arch Klin Exp Ophthalmol 1986; 224: 393-6.
33. Geanon JD, Tripathi BJ, Tripathi RC, Barlow GH. Thissue plasminogen activator in avascular tissues of the eye: a quantitative study of its activity in the cornea, lens, and aqueous and vitreous humors of dog, calf and monkey. Exp Eye Res 1987; 44: 55-63.
34. Ichinose A, Fujikawa K, Suyama T. The activation of prourokinase by plasma kallikrein and its activation by thrombin. J Biol Chem 1986; 261: 3486-89.
35. Gilboa N, Neumann P, Gutmann JM, Del Vecchio PJ, Gudewicz P. Evidence for regulation of endothelial plasminogen-activating systems by polymorphonuclear leukocyte elastase. Thromb Res 1989; 54: 467-75.
36. Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, Günzler WA, Jänicke F, Graeff H. Cathepsin B efficientyl activates the soluble and tumor receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA). J Biol Chem 1991; 266: 5147-52.
37. Stephens RW, Pöllänen J, Tapiovaara H, Leung K, Sim PS, Salonen E-M, Ronne E, Behrendt N, Dano K, Vaheri A. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic systems with surface-bound reactants. J Cell Biol 1989; 108: 1987-95.
38. Holden BA, Sweeney DF, Vannas A, Nilsson KT, Efron N. Effects of long-term extended contact lens wear on the human cornea. Invest. Ophthalmol Vis Sci 1985; 26: 1489-1501.
39. Holden BA, Vannas A, Nilssson K. Epithelial and endothelial effects from extended wear of contact lenses. Current Eye Res 1986; 4, 739-42.
40. Čejková J, Lojda Z, Brůinová B, Vacik J, Michalek J. Disturbances in the rabbit cornea after short-term and long-term wear of hydrogel contact lenses.. Usefulness of histochemical methods. Histochemistry 1988; 89: 91-7.
41. Čejková J, Lojda Z, Vacik J, Digenis G-A, Dropčová S. Histochemical changes in the rabbit cornea and plasmin activity in the tear fluid during contact lens wear. Favourable influence of protease inhibitors (aprotinin, PCS, elastatinal). Histochemistry 1992; 97: 69-72.
42. Madigan MC , Holden BA. Reduced epithelial adhesion after extended contact lens wear correlates with reduced hemidesmosome density in cat cornea. Invest Ophthalmol Vis Sci 1992; 33: 3 14-23.
43. Nieuwendaal CP, Odenthal MTP, Kok JHC, Venema HW, Oosting J, Riemslag FCC, Kijlstra A. Morphology and function of the corneal endothelium after long-term contact lens wear. Invest Ophthalmol Vis Sci 1994; 35: 3071-7.
44. Adams CP, Cohen E Jr, Laibson PR, Galantine P, Arentsen JJ. Corneal ulcers in patients with cosmetic extended-wear contact lenses. Am J Ophthalmol 1983; 96: 705-16.
45. Kirkiand C, Lamberts DW. Marginal corneal ulcers. Curr Eye Res 1985; 4: 736-7.
46. Alfonso E, Mandelbaum S, Fox MJ, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol 1986; 101: 429-33.
47. Tomlinson A, Hans FD. Changes in corneal thickness and circumcorneal vascularization with contact lens wear. Int Contact Lens Clinic 1980; 7: 45-52.
48. Nirankari VS, Karesh J, Lakhanpal V, Richards RD. Deep stromal vascularization associated with cosmetic daily wear contact lenses. Arch Ophthalmol 1983; 103: 47-57.
49. Madigan MC, Penfold PL, Holden BA, Billson FA Ultrastructural features of contact lens-induced deep corneal neovascularization and associated stromal leukocytes. Cornea 1990; 9: 144-51.
50. Masters BR. Effects of contact lenses on the oxygen concentration and epithelial mitochondrial redox state of rabbit cornea measured noninvasively with an optically sectioning redox fluorometer microscope. In: The Cornea: Transactions of the World Congress on the Cornea III. ed. by H.D. Cavanagh, Raven Press, Ltd., New York, 1988; pp. 281-6.
51. Wilson G. The effect of hypoxia on the shedding rate of the corneal epithelium. Current Eye Res 1994; 13: 409-13.
52. Klyce SD. Stromal lactate accumulation can account for corneal oedema osmotically following epithelial hypoxia in the rabbit. J Physiol 1981; 321: 49-63.
53. Thoft RA, Friend J. Biochemical aspects of contact lens wear. Am J Ophthalmol 1975; 80: 130-40.
54. Kilp H. Metabolites and enzymes in the corneal epithelium after extended contact lens wear. Curr Eye Res 1985; 4: 738-9.
55. Ruben M, Brown N, Lobascher D, Chaston J, Morris J. Clinical manifestation secondary to contact lens wear. Br J Ophthalmol 1976; 60: 529-31.
56. Kersley HJ, Kerr C, Pierse D. Hydrophilic lenses for 'continuous wear' in aphakia: definitive fitting and the problems that occur. Brit J Ophthalmol 1977; 61: 38-42.
57. Lobman LE. Corneal epithelial response to contact lens wear. Clao J 1986; 12: 153-6.
58. Tervo T, Van Setten G-B, Anderson R, Vaheri A, Immonen I, Tarkkanen A. Contact lens wear is associated with the appearance of plasmin in the tear fluid - preliminary results. Graefes Arch Clin Exp Ophthalmol 1989; 227: 42-4.
59. Van Setten GB, Tervo T, Andersson R, Perheentupa J, Tarkkanen A. Plasmin and epidermal growth factor in the tear fluid of contact-lens wearers: Effect of wearing different types of contact lenses and association with clinical findings. Ophtahlmic Res 1990; 22: 233-40.
60. Vannas A, Sweeney DF, Holden BA, Sapyska E, Salonen E-M, Vaheri A. Tear plasmin activity with contact lens wear. Curr Eye Res 1992; 11: 259-84.
61. Barlati S, Marchina E, Quaranta CA, Vigasio F, Semerano F. Analysis of fibronectin, plasminogen activators and plasminogen in the tear fluid as markers of corneal damage and repair. Exp Eye Res 1989; 51: 1-9.
62. Granelli-Piperno A, Vassali J-D, Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med 1977; 146: 1693-1706.
63. Reich E. Activation of plasminogen: a general mechanism for producing localized extracellular proteolysis. In: Molecular basis of biological degradative processes. Berlin R, Hermann H, Lepow I, Tanzer J (eds). Academic Press, New York. 1978; pp. 155-70.